1. Articles from Duong C , et al.

    1-1 of 1
    1. Novel targeted therapy for neuroblastoma: Silencing the MXD3 gene using siRNA.

      Novel targeted therapy for neuroblastoma: Silencing the MXD3 gene using siRNA.

      Pediatr Res. 2017 Apr 18;:

      Authors: Duong C, Yoshida S, Chen C, Barisone G, Diaz E, Li Y, Beckett L, Chung J, Antony R, Nolta J, Nitin N, Satake N

      Abstract BACKGROUND: Neuroblastoma is the second most common extracranial cancer in children.

      Read Full Article
    1-1 of 1
  1. Categories

    1. Research:

      Cancer Cell, Case Report, Cells and Stem Cells, Clinical Research, Conferences, Disease Classification, Drug, Drug Delivery, Drug Resistance, Epigenetics and Epigenomics, General, Genetics, Genomics, Guidelines, Immune Therapy, Induction, Long Term Effects, Low / Intermediate Risk, Nanotechnology, Olfactory Neuroblastoma, Onco-Fertility, Oncogenesis, Other Cancers, Personalized Medicine, Pharma, Pre-Clinical, Prognostics, PubMed, Review, Small Molecules, Surgery, Survivorship, Trials, Tumor Biology, Virotherapy
    2. Business:

      Funding, IP, Pharma
    3. Non-Profit:

      Advocacy, Charity, Events, Foundation, Funding, Human Interest
    4. Press Release:

      Announcement, News, Pharma
    5. General:

      Adolescent and Young Adults, Bioethics, Blog, Burden of Treatment, Children & Families, Diagnosis and Detection, Epidemiology, Imaging, Incidence, Information, News, Overview of the Disease, Pain Control, Palliative Care, Psychosocial, Regulation, Side-Effects, Social, Supportive Care, Treatment
    6. Media:

      Audio, Blogs, Video
  2. Topics in the News

    There are no recent topics in the news.

  3. Popular Articles

  4. Picture Gallery

    Century-Old Tumors Offer Rare Cancer Clues Pediatric Cancer Researchers Look To Preserve Reproductive Potential of Survivors Cancer drug to treat deadly neuroblastoma can be prescribed on Nhs - new hope for children Testing a new immunotherapy treatment for neuroblastoma Fighting cancer with immunotherapy: Signaling molecule causes regression of blood vessels Fighting cancer with immunotherapy: Signaling molecule causes regression of blood vessels Latest data show a global increase of 13% in childhood cancer incidence over two decades Success of sensory cell regeneration raises hope for hearing restoration Study finds more childhood cancer survivors would likely benefit from genetic screening Biomarker may identify neuroblastoma patients most likely to benefit from immunotherapy Biomarker May Identify Neuroblastoma Patients Most Likely to Benefit from Immunotherapy Little Opposition to Early Palliative Care for Symptom Management in Pediatric Oncology